Exelixis
EXEL
#1361
Rank
ยฃ12.21 B
Marketcap
ยฃ49.30
Share price
-0.12%
Change (1 day)
64.99%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: ยฃ12.21 Billion

As of October 2026 Exelixis has a market cap of ยฃ12.21 Billion. This makes Exelixis the world's 1361th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ12.21 B32.16%
2025ยฃ9.24 B20.13%
2024ยฃ7.69 B31.39%
2023ยฃ5.85 B36.92%
2022ยฃ4.27 B-0.19%
2021ยฃ4.28 B-6.2%
2020ยฃ4.56 B11.89%
2019ยฃ4.08 B-12.14%
2018ยฃ4.64 B-30.17%
2017ยฃ6.65 B89.96%
2016ยฃ3.50 B303.8%
2015ยฃ0.86 B378.84%
2014ยฃ0.18 B-73.58%
2013ยฃ0.68 B32.03%
2012ยฃ0.51 B25.77%
2011ยฃ0.41 B-28.95%
2010ยฃ0.58 B18.25%
2009ยฃ0.49 B35.89%
2008ยฃ0.36 B-20.51%
2007ยฃ0.45 B3.17%
2006ยฃ0.44 B-3.19%
2005ยฃ0.45 B22.77%
2004ยฃ0.37 B32.07%
2003ยฃ0.28 B-5.17%
2002ยฃ0.29 B-53.96%
2001ยฃ0.64 B40.55%
2000ยฃ0.45 B

End of Day market cap according to different sources

On Oct 29th, 2026 the market cap of Exelixis was reported to be:

ยฃ12.21 Billion
by Nasdaq info icon info icon
ยฃ12.21 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ493.38 B 3,938.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ127.13 B 940.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ185.50 B 1,418.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ76.96 B 530.03%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ268.86 B 2,100.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ93.45 B 665.01%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ72.63 B 494.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
ยฃ0.99 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
ยฃ0.38 B-96.82%๐Ÿ‡บ๐Ÿ‡ธ USA